Global Smart Inhalers Market

$2,600.00

产品代码: GH02196R 行业: 地区:

Inhalers are used to treat chronic obstructive pulmonary disease (COPD), such as asthma, by delivering bronchodilator medication to the airway directly, without passing through the blood. A smart inhaler is an inhaler that integrates connectivity with a mobile app, via Bluetooth, for instance. These devices are built with sensor technology that helps record data about the time and date of use, and the location of the patient at each use. The global smart inhalers market is likely to register a CAGR of over 21.7% 随着美元的增量增长 536 预测期内 百万 2022-2028.

该报告提供了有关当前全球市场情况的深入分析和见解, latest trends and drivers into global smart inhalers market. 它提供了对市场规模等各种细节的独家见解, 主要趋势, 竞争格局, 增长率和细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the smart inhalers industry.

该行业报告提供了全球市场的市场估计和预测, 接下来是对产品的详细分析, disorder, 和地区. The global market for smart inhalers can be segmented by product: dry powder inhaler (DPI)-based smart inhalers , metered-dose inhaler (MDI)-based smart inhalers. The MDI-based smart inhalers segment held the largest share of the global smart inhalers market in 2021 预计在预测期内将持有其份额. Smart inhalers market is further segmented by disorder: asthma, chronic obstructive pulmonary disease (COPD). 全球范围, the asthma segment made up the largest share of the smart inhalers market. 根据地区, the smart inhalers market is segmented into: 亚太地区, 欧洲, 北美, 世界其他地区 (排). Europe was the largest contributor to the global smart inhalers market in 2021.

副产品:
dry powder inhaler (DPI)-based smart inhalers
metered-dose inhaler (MDI)-based smart inhalers

By disorder:
asthma
chronic obstructive pulmonary disease (COPD)

按地区:
– 亚太地区
– 欧洲
– 北美
– 世界其他地区 (排)

The report also provides a detailed analysis of several leading smart inhalers market vendors that include AstraZeneca plc, 勃林格殷格翰国际有限公司, 葛兰素史克公司 (GSK), Heitkamp & Thumann KG, 诺华国际公司, OPKO Health, 公司. (OPK), 梯瓦制药工业有限公司, Vectura Group plc, 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global smart inhalers market.
To classify and forecast the global smart inhalers market based on product, disorder, 地区.
To identify drivers and challenges for the global smart inhalers market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global smart inhalers market.
To identify and analyze the profile of leading players operating in the global smart inhalers market.

为什么选择这份报告
Gain a reliable outlook of the global smart inhalers market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Smart Inhalers Market

对这份报告感兴趣? 立即获取免费样品!
Global Smart Inhalers Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

21.7%

页数

85

行业参与者

阿斯利康公司, 勃林格殷格翰国际有限公司, 葛兰素史克公司 (GSK), Heitkamp & Thumann KG, 诺华国际公司, OPKO Health Inc. (OPK), 梯瓦制药工业有限公司, Vectura Group plc

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Smart Inhalers Market

请填写我们的表格,我们会尽快回复您.